Late gadolinium enhancement and sudden cardiac death in hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 57, Issue 12, 2011, Pages 1402-

  Chiribiri, Amedeo ^b   Conte, Maria Rosa ^b   Bonamini, Rodolfo ^b   Gaita, Fiorenzo ^b   Nagel, Eike ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

CONTRAST ENHANCEMENT; DEFIBRILLATION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FOLLOW UP; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LATE GADOLINIUM ENHANCEMENT; LETTER; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RISK ASSESSMENT; SUDDEN DEATH;

EID: 79952650963     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.09.076     Document Type: Letter

References (5)

1. Bruder O, Wagner A, Jensen CJ, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
2. O'Hanlon R, Grasso A, Roughton M, et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
3. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:2156-64. (Pubitemid 36005903)
4. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation 2000;102:858-64.
5. Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418-25. (Pubitemid 46717964)